Home › Disfunction ng Kaliwang Ventrikulo › Ohio
Pag-aaral pangklinika para sa Disfunction ng Kaliwang Ventrikulo sa Ohio
4 pag-aaral para sa Disfunction ng Kaliwang Ventrikulo ang naghahanap ng mga kalahok sa mga site sa Ohio.
Mga Lungsod sa Ohio
Opisyal na teksto ng pag-aaral (English)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Cincinnati Children's Hospital Medical Center ( Site 0034), Cincinnati
- Cleveland Clinic-Cleveland Clinic Chidren's ( Site 0022), Cleveland
Nagre-recruitPhase 2/3
29 Days – 17 Years · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05714085A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
- Cleveland Clinic Children's, Cleveland
- Nationwide Children's Hospital - Cardiology, Columbus
Nagre-recruitPhase 3
Hanggang edad 18 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
- Cleveland Clinic Children's, Cleveland
- Nationwide Children's Hospital - Cardiology, Columbus
Nagre-recruitPhase 3
6 Months – 17 Years · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT07188805The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- University Hospitals Cleveland Medical Center, Cleveland
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT05427370Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.